Companies › XFOR

X4 PHARMACEUTICALS INC (XFOR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001501697 · EDGAR filings · Updated 2026-07-01

X4 PHARMACEUTICALS INC (XFOR) has reported institutional ownership of 99.5%, with 82 institutional managers holding positions valued at $373.7M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-01 — Insider transaction reported (Form 4)
• 2026-07-01 — Insider transaction reported (Form 4)
• 2026-07-01 — Initial insider ownership filed (Form 3)
• 2026-07-01 — Current report (8-K) filed
• 2026-05-15 — SCHEDULE 13G/A filed
• 2026-05-14 — EFFECT filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, X4 PHARMACEUTICALS INC has 82 institutional holders and institutional ownership of 99.5%.

Insider activity

Insiders reported 13 transactions (2 buys, 0 sells) across 11 reporting insiders, with a net reported value of $252.6K.

Data flags from SEC filings

Related companies

CRYOPORT INC (CYRX) · ABSCI CORPORATION (ABSI) · ASSEMBLY BIOSCIENCES INC (ASMB) · CYTEK BIOSCIENCES INC (CTKB) · NATURES SUNSHINE PRODS INC (NATR) · SHATTUCK LABS INC (STTK)